🚀 VC round data is live in beta, check it out!
Vimian Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Vimian Group and similar public comparables like SonoScape, Fleury, Diagnostyka, Wandong Medical and more.
Vimian Group Overview
About Vimian Group
Vimian Group AB specializes in the areas of animal health, such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals, with a position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.
Founded
2020
HQ
Employees
1.2K
Website
Financials (LTM)
EV
$2B
Vimian Group Financials
Vimian Group reported last 12-month revenue of $518M and EBITDA of $143M.
In the same LTM period, Vimian Group generated $356M in gross profit, $143M in EBITDA, and $45M in net income.
Revenue (LTM)
Vimian Group P&L
In the most recent fiscal year, Vimian Group reported revenue of $505M and EBITDA of $138M.
Vimian Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $518M | XXX | $505M | XXX | XXX | XXX |
| Gross Profit | $356M | XXX | $345M | XXX | XXX | XXX |
| Gross Margin | 69% | XXX | 68% | XXX | XXX | XXX |
| EBITDA | $143M | XXX | $138M | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | 27% | XXX | XXX | XXX |
| EBIT Margin | 19% | XXX | 19% | XXX | XXX | XXX |
| Net Profit | $45M | XXX | $39M | XXX | XXX | XXX |
| Net Margin | 9% | XXX | 8% | XXX | XXX | XXX |
| Net Debt | — | — | $198M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Vimian Group Stock Performance
Vimian Group has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Vimian Group's stock price is $3.37.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.3% | XXX | XXX | XXX | $0.07 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialVimian Group Valuation Multiples
Vimian Group trades at 3.9x EV/Revenue multiple, and 14.0x EV/EBITDA.
EV / Revenue (LTM)
Vimian Group Financial Valuation Multiples
As of April 19, 2026, Vimian Group has market cap of $2B and EV of $2B.
Equity research analysts estimate Vimian Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Vimian Group has a P/E ratio of 39.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 3.9x | XXX | 3.9x | XXX | XXX | XXX |
| EV/EBITDA | 14.0x | XXX | 14.5x | XXX | XXX | XXX |
| EV/EBIT | 20.4x | XXX | 21.2x | XXX | XXX | XXX |
| EV/Gross Profit | 5.6x | XXX | 5.8x | XXX | XXX | XXX |
| P/E | 39.2x | XXX | 45.9x | XXX | XXX | XXX |
| EV/FCF | 29.2x | XXX | 18.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Vimian Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Vimian Group Margins & Growth Rates
Vimian Group's revenue in the last 12 month grew by 9%.
Vimian Group's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Vimian Group's rule of 40 is 38% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Vimian Group's rule of X is 52% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Vimian Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | 27% | XXX | XXX | XXX |
| EBITDA Growth | 13% | XXX | 12% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 38% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 52% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 52% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Vimian Group Public Comps
See public comps and valuation multiples for other Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Vimian Group | XXX | XXX | XXX | XXX | XXX | XXX |
| SonoScape | XXX | XXX | XXX | XXX | XXX | XXX |
| Fleury | XXX | XXX | XXX | XXX | XXX | XXX |
| Diagnostyka | XXX | XXX | XXX | XXX | XXX | XXX |
| Wandong Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| GRAIL | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Vimian Group M&A Activity
Vimian Group acquired XXX companies to date.
Last acquisition by Vimian Group was on XXXXXXXX, XXXXX. Vimian Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Vimian Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialVimian Group Investment Activity
Vimian Group invested in XXX companies to date.
Vimian Group made its latest investment on XXXXXXXX, XXXXX. Vimian Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Vimian Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Vimian Group
| When was Vimian Group founded? | Vimian Group was founded in 2020. |
| Where is Vimian Group headquartered? | Vimian Group is headquartered in Sweden. |
| How many employees does Vimian Group have? | As of today, Vimian Group has over 1K employees. |
| Who is the CEO of Vimian Group? | Vimian Group's CEO is Patrik Eriksson. |
| Is Vimian Group publicly listed? | Yes, Vimian Group is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Vimian Group? | Vimian Group trades under VIMIAN ticker. |
| When did Vimian Group go public? | Vimian Group went public in 2021. |
| Who are competitors of Vimian Group? | Vimian Group main competitors are SonoScape, Fleury, Diagnostyka, Wandong Medical. |
| What is the current market cap of Vimian Group? | Vimian Group's current market cap is $2B. |
| What is the current revenue of Vimian Group? | Vimian Group's last 12 months revenue is $518M. |
| What is the current revenue growth of Vimian Group? | Vimian Group revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Vimian Group? | Current revenue multiple of Vimian Group is 3.9x. |
| Is Vimian Group profitable? | Yes, Vimian Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Vimian Group? | Vimian Group's last 12 months EBITDA is $143M. |
| What is Vimian Group's EBITDA margin? | Vimian Group's last 12 months EBITDA margin is 28%. |
| What is the current EV/EBITDA multiple of Vimian Group? | Current EBITDA multiple of Vimian Group is 14.0x. |
| What is the current FCF of Vimian Group? | Vimian Group's last 12 months FCF is $68M. |
| What is Vimian Group's FCF margin? | Vimian Group's last 12 months FCF margin is 13%. |
| What is the current EV/FCF multiple of Vimian Group? | Current FCF multiple of Vimian Group is 29.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.